Pathophysiological Mechanisms of Diabetic Nephropathy: Role of S1R/Nrf2 Antioxidant Axis

Overview of key molecular processes behind diabetic nephropathy

AMELIORATIVE EFFECT OF PIOGLITAZONE AND ROUSVASTATIN ON HFD/STZ-INDUCED HEPATIC INJURY IN RATS

Metrnl impact in streptozotocin induced diabetic nephropathy in rats, targeting Nrf2/HO-1 pathway

Role of Cystathionine Gamma Lyasein Diabetic Nephropathy

Maresin-1 mitigates streptozotocin induced diabetic nephropathy in rats via up-regulation of Nrf2/HO-1 pathway

The Efficacy of Canagliflozin on Type 2 Diabetic Nephropathy in Male Rats

PPARγ UPREGULATION MEDIATES THE ANTIDIABETIC POTENTIAL OF KAEMPFEROL IN HIGH FAT DIET/STREPTOZOTOCIN-INDUCED DIABETIC RATS

MALAT1 Gene Expression in Diabetic Patients with or without Nephropathy

Effects of rosiglitazone and telmisartan on experimentally induced diabetic nephropathy in rats